Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Immunology

• Publication date

  2013-03-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ni.2550PMID 23502856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small-molecule inhibitors of the AAA+ ATPase motor cytoplasmic dynein

  2012cited by this paper
• Activation of the NLRP 3 Inflammasome

  2012cited by this paper
• Inflammasomes in health and disease

  2012cited by this paper
• GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals

  2012cited by this paper
• Structures containing Atg9A and the ULK1 complex independently target depolarized mitochondria at initial stages of Parkin-mediated mitophagy

  2012cited by this paper
• Mitochondria: In Sickness and in Health

  2012cited by this paper
• Mitochondrial ROS fuel the inflammasome

  2011cited by this paper
• Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.

  2011cited by this paper
• Adenovirus Type 5 Rupture of Lysosomes Leads to Cathepsin B-Dependent Mitochondrial Stress and Production of Reactive Oxygen Species

  2011cited by this paper
• Intracellular sensors of microbes and danger

  2011cited by this paper
• Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling

  2011cited by this paper
• Mitochondrial reactive oxygen species drive proinflammatory cytokine production

  2011cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• ER sliding dynamics and ER–mitochondrial contacts occur on acetylated microtubules

  2010cited by this paper
• Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

  2010cited by this paper
• MEC-17 is an α-tubulin acetyltransferase

  2010cited by this paper
• NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease

  2010cited by this paper
• NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

  2010cited by this paper
• Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella

  2010cited by this paper
• Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

  2010cited by this paper
• Regulation of innate immune responses by autophagy-related proteins

  2010cited by this paper
• Post-translational modifications of microtubules

  2010cited by this paper
• Influenza virus activates inflammasomes through intracellular M2 channel

  2010cited by this paper
• Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity

  2010cited by this paper
• Parkin‐mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network

  2010cited by this paper
• The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance

  2010cited by this paper
• Regulators of the cytoplasmic dynein motor

  2009cited by this paper
• AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC

  2009cited by this paper
• Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

  2008cited by this paper
• Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

  2008cited by this paper
• The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity

  2008cited by this paper
• Tissue-specific regulation of SIRT1 by calorie restriction.

  2008cited by this paper
• Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production

  2008cited by this paper
• Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation

  2007cited by this paper
• Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules.

  2006cited by this paper
• Microtubule acetylation promotes kinesin-1 binding and transport.

  2006cited by this paper
• Interleukin-6 and chronic inflammation

  2006cited by this paper
• The inflammatory process of gout and its treatment

  2006cited by this paper
• Gout-associated uric acid crystals activate the NALP3 inflammasome

  2006cited by this paper
• Role of sodium in mitochondrial membrane depolarization induced by P 2 X 7 receptor activation in submandibular glands

  2005cited by this paper
• Role of sodium in mitochondrial membrane depolarization induced by P2X7 receptor activation in submandibular glands

  2005cited by this paper
• Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

  2004cited by this paper
• The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

  2003cited by this paper
• Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin

  2003cited by this paper
• HDAC6 is a microtubule-associated deacetylase

  2002cited by this paper
• Colchicine has opposite effects on interleukin-1 beta and tumor necrosis factor-alpha production.

  1991cited by this paper
• Colchicine has opposite effects on interleukin-1β and tumor necrosis factor-α production

  1991cited by this paper
• 'In sickness and health'.

  1979cited by this paper
• Dynamics and mechanics of the microtubule plus end

  year unknowncited by this paper
• Serveur Académique Lausannois SERVAL serval.unil.ch

  year unknowncited by this paper

• Methylglyoxal-modification of NLRP3 interrupts NLRP3-NEK7 interaction diminishing inflammasome activation and neuroinflammation

  2026influential citation
• Gut-heart axis disruption and LPS translocation: driving atrial fibrillation through inflammatory storm and fibrotic mechanisms

  2026cites this paper
• NLRP3 inflammasome and Alzheimer’s disease: bridging inflammation and neurodegeneration

  2026cites this paper
• Regulation of apoptosis, ferroptosis, and pyroptosis mediated by acetylation

  2026cites this paper
• Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity.

  2026cites this paper
• SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges

  2026cites this paper
• The impact of post-translational modifications and subcellular localization on NLRP3 inflammasome activation: A systematic review

  2025cites this paper
• Endoplasmic reticulum-mediated organelle crosstalk in kidney disease

  2025cites this paper
• A novel AGBL3 variant potentially associated with hypocomplementemic urticarial vasculitis syndrome: examining clinical outcomes and therapeutic responses.

  2025cites this paper
• Updated insights into the molecular networks for NLRP3 inflammasome activation

  2025cites this paper
• Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly

  2025cites this paper
• Nitroxoline is a novel inhibitor of NLRP3-dependent pyroptosis

  2025cites this paper
• ALDH2 Ameliorates Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and Pyroptosis by Nrf2/ROS Pathway

  2025cites this paper
• β-Nicotinamide adenine dinucleotide (β-NAD) acts as a bronchodilator

  2025cites this paper
• Mitochondria-organelle crosstalk in establishing compartmentalized metabolic homeostasis.

  2025cites this paper
• Nanotube topography inhibits NLRP3 inflammasome activation by reducing microtubule glutamylation

  2025cites this paper
• Mechano-metabolic dysregulation in osteoarthritis: Piezo1-mediated mitophagy impairment as a novel therapeutic target

  2025cites this paper
• Oxidative Stress, Mitochondrial Quality Control, Autophagy, and Sirtuins in Heart Failure

  2025cites this paper
• A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies.

  2025cites this paper
• Disruption of intracellular calcium homeostasis drives graphene quantum dots-induced inflammatory response in liver macrophages

  2025cites this paper
• ACLY inhibitor reduced Porphyromonas gingivalis-induced pyroptosis by suppressing microtubules acetylation in macrophages.

  2025cites this paper
• Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation

  2025cites this paper
• Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations

  2025cites this paper
• Targeting Mitochondrial Dysfunction: Innovative Strategies to Combat Glaucoma Neuroinflammation.

  2025cites this paper
• Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.

  2025cites this paper
• Sulforaphane-cysteine inhibits α-tubulin/PD-L1/PFKFB4 axis leading to apoptosis in human glioblastoma

  2025cites this paper
• Cholesterol Crystals as Triggers of NLRP3 Inflammasome Activation in Atherosclerosis

  2025cites this paper
• Organelles and cancer cell pyroptosis: overview and perspectives

  2025cites this paper
• Mitochondrial damage and IL-1β production in monocytes caused by Neospora caninum infection are mediated by dense granule protein 7 and prohibitins

  2025cites this paper
• Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations

  2025cites this paper
• Colchicine for Major Adverse Cardiovascular Events: An Updated ChatGPT-Assisted Systematic Review and Meta-Analysis.

  2025cites this paper
• Lipid-laden macrophages in atherosclerosis and cancer.

  2025cites this paper
• Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases.

  2025cites this paper
• Sirtuins in Parkinson's Disease: Molecular Mechanisms and Pathophysiological Roles.

  2025cites this paper
• New perspectives on the NLRP3 inflammasome—colchicine and the suppression of inflammatory pathways in metabolic syndrome associated diseases

  2025cites this paper
• Mitochondria‐associated membranes (MAMs): molecular organization, cellular functions, and their role in health and disease

  2025cites this paper
• Exploring the interplay between mitochondria and endoplasmic reticulum in pulmonary arterial hypertension

  2025cites this paper
• Actin cytoskeleton stabilization inhibits NLRP3 inflammasome activation and mitigates renal inflammation and fibrosis in obstructive nephropathy.

  2025cites this paper
• Unraveling the potential of neuroinflammation and autophagy in schizophrenia.

  2025cites this paper
• Cardiomyocyte mitochondrial mono-ADP-ribosylation dictates cardiac tolerance to sepsis by configuring bioenergetic reserve in male mice

  2025cites this paper
• Dual-drug nanocarriers for gout therapy: targeted co-delivery of anti-inflammatory and urate-lowering agents: a review

  2025cites this paper
• Therapeutic connections between pyroptosis and paclitaxel in anti-tumor effects: an updated review

  2025cites this paper
• The impact of uric acid on musculoskeletal diseases: clinical associations and underlying mechanisms

  2025cites this paper
• The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization

  2025cites this paper
• Colchicin – Phönix aus der Asche

  2025cites this paper
• The fundamental role of mitochondria–endoplasmic reticulum contacts in ageing and declining healthspan

  2025cites this paper
• Inflammasome Activation and Neutrophil Extracellular Traps in Atherosclerosis

  2025cites this paper
• Gout and NLRP3 Inflammasome Biology

  2025influential citation
• Investigation of “Microbial-mitochondrial” cross-talk to explore the compatibility mechanism of Xiaojianzhong Tang against chronic atrophic gastritis rats

  2025cites this paper
• Modulation of NLRP3 Inflammasome: Advantages of Chinese Herbal Medicine in Treating Myocardial Ischemia/Reperfusion Injury.

  2025cites this paper
• Exploring the global research trends and precise therapeutic indications of colchicine for coronary heart disease: A bibliometric systematic review and meta-analysis

  2025cites this paper
• Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trials

  2025cites this paper
• Identification of pyroptosis related genes and subtypes in atherosclerosis using multiomic and single cell analysis

  2025cites this paper
• Jianpi Qushi Heluo formula ameliorates podocytes injury related with ROS-mediated NLRP3 inflammasome activation in membranous nephropathy by promoting PINK1-dependent mitophagy

  2025cites this paper
• Tubulin targeting agents and their implications in non-cancer disease management.

  2025cites this paper
• Synergistic Effects of LPS and MSU on NF-κB/NLRP3-mediated Inflammation in Fibroblast Cells

  2025cites this paper
• Colchicine and Atherosclerotic Coronary Artery Disease: An Updated Review

  2025cites this paper
• Colchicine Only Inhibits in Higher Doses Hyperactivated NLRP3 Inflammasome-The Main Respondent for Complications in COVID-19 and Influenza.

  2025cites this paper
• Molecular Mechanisms of Chronic Pain and Therapeutic Interventions

  2025cites this paper
• Histone Deacetylase 6 Regulates α-Tubulin to Inhibit the Stimulator of Interferon Genes/NLR Family Pyrin Domain-Containing 3-Mediated Microglial Pyroptosis Induced by Herpes Simplex Virus Type 1 Infection.

  2025cites this paper
• Neutrophils loaded NAD+ impede TLR4/NF-κB/NLRP3 pathway for sepsis treatment

  2025cites this paper
• Clinical Use and Effectiveness of Colchicine for Secondary Prevention following Acute Myocardial Infarction.

  2025cites this paper
• Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases.

  2025cites this paper
• Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?

  2025cites this paper
• Effect of Oral Administration of Colchicine on Progression of Aortic Aneurysm in Mice.

  2025cites this paper
• High colchicine doses are more effective in COVID-19 outpatients than nirmatrelvir/ritonavir, remdesivir, and molnupiravir

  2025cites this paper
• Revealing the dance of NLRP3: spatiotemporal patterns in inflammasome activation

  2025cites this paper
• Succinate in innate immunity: linking metabolic reprogramming to immune modulation

  2025cites this paper
• Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis

  2025cites this paper
• The mitochondria as a potential therapeutic target in cerebral I/R injury

  2025cites this paper
• Efficacy and safety of colchicine in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Effects of exercise on neuroinflammation in age-related neurodegenerative disorders

  2025cites this paper
• Ubiquitination in pyroptosis pathway: A potential therapeutic target for sepsis.

  2024cites this paper
• Beyond Genes: Epiregulomes as Molecular Commanders in Innate Immunity.

  2024cites this paper
• Publication trends and research hotspots of IL-1: A bibliometric analysis of IL-1 with relevance to anesthesia in highly cited papers from WoSCC

  2024cites this paper
• The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan

  2024cites this paper
• Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis

  2024cites this paper
• NLRP3 Negative Regulation Mechanisms in the Resting State and Its Implications for Therapeutic Development

  2024cites this paper
• Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

  2024cites this paper
• Shaping cardiac destiny: the role of post-translational modifications on endoplasmic reticulum – mitochondria crosstalk in cardiac remodeling

  2024cites this paper
• Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID-19

  2024cites this paper
• Functional identification of soluble uric acid as an endogenous inhibitor of CD38

  2024cites this paper
• Regulation of the NLRP3 inflammasome by autophagy and mitophagy

  2024cites this paper
• Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice

  2024cites this paper
• The Effect of Low‐Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double‐Blind Randomized Placebo‐Controlled Cross‐Over Study

  2024cites this paper
• Genetic and epigenetic regulation of inflammasomes: Role in atherosclerosis.

  2024cites this paper
• Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome

  2024cites this paper
• Current Challenges and Emerging Therapies in the Treatment of Gout.

  2024cites this paper
• RETRACTED ARTICLE: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes

  2024cites this paper
• Role of NLRP3 Inflammasome in Pathogenesis of Ischemic Stroke

  2024cites this paper
• LincRNA-p21/AIF-1/CMPK2/NLRP3 pathway promoted inflammation, autophagy and apoptosis of human tubular epithelial cell induced by urate via exosomes

  2024cites this paper
• Gelsolin alleviates rheumatoid arthritis by negatively regulating NLRP3 inflammasome activation

  2024cites this paper
• Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke

  2024cites this paper
• Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.

  2024cites this paper
• NLRP3 Inflammasome: A central player in renal pathologies and nephropathy.

  2024cites this paper
• Investigation of crucial genes and mitochondrial function impairment in diabetic cardiomyopathy.

  2024cites this paper
• SIRTUIN 5 ALLEVIATES EXCESSIVE MITOCHONDRIAL FISSION VIA DESUCCINYLATION OF ATPASE INHIBITORY FACTOR 1 IN SEPSIS-INDUCED ACUTE KIDNEY INJURY

  2024cites this paper
• A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation

  2024cites this paper
• Sound Matrix Shaping of Living Matter: From Macrosystems to Cell Microenvironment, Where Mitochondria Act as Energy Portals in Detecting and Processing Sound Vibrations

  2024cites this paper
• Circadian Rhythms in NLRP3 Inflammasome Regulation: Possible Implications for the Nighttime Risk of Gout Flares

  2024cites this paper